• Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation

  2026-05-20

  Phos binding reagent (Phosbind) Biotin from APExBIO enables sequence-independent, highly sensitive detection of phosphorylated proteins in Western Blots, streamlining workflows in plant stress and disease research. Its dinuclear metal complex phosphate binding mechanism offers a robust alternative to phospho-specific antibodies, particularly for complex signal transduction analyses.

• Synergistic Antitumor Immunity via Radiotherapy and Dual Che

  2026-05-20

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT immune checkpoint inhibitors elicits potent abscopal effects and durable immune memory, mediated by activated CD8+ T cells. These findings illuminate mechanisms of resistance to PD-1 monotherapy and provide a rational basis for advancing combination immunoradiotherapy strategies in cancer research.

• Annexin A7 Links Dynein to Prevent Axonal TIA1 Aggregation

  2026-05-19

  This study reveals that Annexin A7 is essential for linking TIA1-containing ribonucleoprotein complexes to dynein, enabling retrograde axonal transport and preventing neurotoxic protein aggregation. The findings advance understanding of axonal mRNA trafficking and its direct connection to neurodegenerative pathology.

• Validated HPLC Assay for Trelagliptin Succinate and Impuriti

  2026-05-19

  This study presents a rigorously validated HPLC method for quantifying trelagliptin succinate (SYR-472 succinate) and its process-related impurities in pharmaceutical dosage forms. The method demonstrates high specificity, sensitivity, and stability-indicating capability, providing researchers and manufacturers with a robust tool for quality control where no official monograph exists.

• Glioma Stem Cell Membrane Nanozymes Enable Dual-Targeted GBM

  2026-05-18

  This study introduces a glioma stem cell membrane-camouflaged nanozyme system capable of crossing the blood–brain barrier and delivering doxorubicin for synergistic chemo- and photothermal therapy in glioblastoma models. The innovation provides a significant survival extension in mice and offers new strategies for targeting therapy-resistant tumor subpopulations.

• D-Luciferin (Potassium Salt): Illuminating Photosynthetic an

  2026-05-18

  Explore how D-Luciferin (potassium salt) transforms in vivo bioluminescence imaging and luciferase reporter assays. This article uniquely bridges plant photosynthetic research with advanced animal model applications, deepening understanding for assay design.

• Viperin Disrupts Coronavirus Replication via nsp8-RTC Interf

  2026-05-17

  The referenced study unveils a novel antiviral mechanism by which viperin, an interferon-induced protein, inhibits coronavirus replication. By directly binding to non-structural protein 8 (nsp8), viperin disrupts replication-transcription complex (RTC) assembly independently of its canonical RNA chain-terminating product, ddhCTP. These findings broaden our understanding of viperin's antiviral activity and suggest new strategies for targeting conserved coronavirus machinery.

• Tacrolimus (FK506): Mechanism and Applications in Immunology

  2026-05-16

  Tacrolimus (FK506) is a highly potent, selective macrolide immunosuppressant that inhibits calcineurin via FKBP12 complexation. It is widely used in transplantation immunology research and autoimmune disease models for its precise cytokine pathway modulation. This dossier details its mechanism, quantitative benchmarks, and critical protocol parameters.

• CKI 7 Dihydrochloride: Advancing CK1 Inhibition in Cancer Re

  2026-05-15

  This article explores the mechanistic and translational impact of CKI 7 dihydrochloride, a selective Casein kinase 1 inhibitor, for dissecting key signaling pathways in cancer biology—especially Wnt and circadian rhythm regulation. Building on recent insights into kinase-controlled metastasis in non-small cell lung cancer, we provide strategic guidance for researchers seeking to leverage CKI 7 dihydrochloride in high-impact experimental designs, with evidence-based protocol parameters, workflow recommendations, and a forward-looking perspective on clinical translation.

• Rotigotine: Dopamine D2/D3 Receptor Agonist for Translationa

  2026-05-15

  Rotigotine, a high-affinity dopamine D2/D3 receptor agonist, is redefining experimental Parkinson’s disease research through continuous dopaminergic delivery and robust multi-receptor modulation. This article breaks down in vitro and in vivo applications, protocol optimizations, and troubleshooting steps that maximize reproducibility and data clarity.

• Palomid 529 (P529) in Overcoming Metastasis and Resistance v

  2026-05-14

  Explore how Palomid 529 (P529) uniquely addresses cancer metastasis and chemoresistance through dual mTORC1/mTORC2 inhibition. This in-depth analysis leverages new mechanistic insights for assay strategy and translational research.

• MOB1A/B Loss Disrupts Intestinal Homeostasis via TGF-β and W

  2026-05-14

  This study reveals that depletion of MOB1A/B in intestinal epithelial cells leads to degeneration through suppression of Wnt activity and activation of BMP/TGF-β signaling. Pharmacological inhibition of the TGF-β pathway with SB 431542 partially restores differentiation of secretory lineages, highlighting a critical regulatory axis for intestinal homeostasis.

• Z-LEHD-FMK: Strategic Caspase-9 Inhibition for Translational

  2026-05-13

  Explore how Z-LEHD-FMK, a selective irreversible caspase-9 inhibitor, empowers translational researchers to dissect mitochondria-mediated apoptosis in cancer and neuroprotection models. This article synthesizes mechanistic insight, recent advances in apoptosis assays, and strategic recommendations for leveraging Z-LEHD-FMK in disease modeling, with evidence from melanoma nanomaterial studies and advanced protocol guidance.

• Glabridin-Gold(I) Complex Targets TrxR/MAPK for Antitumor Im

  2026-05-13

  This study introduces a novel glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase and MAPK pathways to enhance antitumor immune responses while mitigating immunosuppression in liver cancer models. The findings highlight mechanistic advances in immunomodulation and offer new directions for combination immunotherapy strategies.

• Strategic Apoptosis Modulation: Caspase-3/7 Inhibitor I in T

  2026-05-12

  This thought-leadership article explores the mechanistic, experimental, and translational facets of Caspase-3/7 Inhibitor I as a tool for apoptosis research. Integrating recent pathogen-induced apoptosis findings, it provides actionable guidance for researchers designing studies in cancer, infection, and cell survival. The article contextualizes APExBIO's inhibitor within contemporary research, protocol best practices, and future clinical translation.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page